JD vs TRDA · P/E 7.6, rev $187.20B vs P/E 12, rev $210.8M
JD.com Inc Adr (JD) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
JD.com Inc Adr (JD) is a internet retail company listed on US.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported JD revenue for 2025-12-31 was $187.20B. Net income was $3.31B. Revenue was up 17.9% from 2024-12-31 to 2025-12-31. JD currently screens at market cap $45.56B and trailing P/E 7.6.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
JD currently screens at market cap $45.56B and trailing P/E 7.6. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the JD and TRDA stock pages for the full models.
Not investment advice.